• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组水蛭素(CGP 39393)在血浆中的抗凝作用机制。

The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.

作者信息

Lindhout T, Blezer R, Hemker H C

机构信息

Department of Biochemistry, University of Limburg, Maastricht, The Netherlands.

出版信息

Thromb Haemost. 1990 Nov 30;64(3):464-8.

PMID:2096492
Abstract

We studied the inhibitory action of recombinant desulphatohirudin (CGP 39393) on thrombin generation in whole plasma. Human plasma was activated either with thromboplastin or factor IXa. Hirudin delayed thrombin generation, but it was unable to prevent the explosive appearance of thrombin. The dose-dependent prolongation of the lag phase of the intrinsic and extrinsic thrombin generation curve was not the result of titration of thrombin activity by hirudin but the result of a delayed formation of the prothrombin converting complex (prothrombinase). In case of extrinsic activation, hirudin did not affect factor Xa generation, but prolonged the lag phase of the factor Va generation curve, causing its appearance when factor Xa generation was already in the decay phase. Because of its inhibitory action on the thrombin-mediated activation of factor VIII, hirudin prolonged the lag phase of the factor X converting complex that consists of factor IXa and factor VIIIa. Our observations with hirudin are in keeping with the notion that inhibition of the thrombin-mediated amplification reactions in blood coagulation is a very efficient way to delay or inhibit completely thrombin generation. However, although hirudin neutralizes stoichiometric amounts of thrombin, the interaction between in situ generated thrombin and hirudin appears not to be fast enough to prevent trace amounts of thrombin to activate factors VIII and V. Consequently, an explosive thrombin generation is observed even when free hirudin is present.

摘要

我们研究了重组去硫酸水蛭素(CGP 39393)对全血中凝血酶生成的抑制作用。用人凝血活酶或因子IXa激活人血浆。水蛭素延迟了凝血酶的生成,但无法阻止凝血酶的爆发性出现。内源性和外源性凝血酶生成曲线滞后相的剂量依赖性延长并非水蛭素滴定凝血酶活性的结果,而是凝血酶原转化复合物(凝血酶原酶)形成延迟的结果。在外源性激活的情况下,水蛭素不影响因子Xa的生成,但延长了因子Va生成曲线的滞后相,导致其在因子Xa生成已进入衰减期时出现。由于其对凝血酶介导的因子VIII激活的抑制作用,水蛭素延长了由因子IXa和因子VIIIa组成的因子X转化复合物的滞后相。我们对水蛭素的观察结果与以下观点一致,即抑制血液凝固中凝血酶介导的放大反应是延迟或完全抑制凝血酶生成的非常有效的方法。然而,尽管水蛭素能按化学计量中和凝血酶,但原位生成的凝血酶与水蛭素之间的相互作用似乎不够快,无法阻止痕量凝血酶激活因子VIII和V。因此,即使存在游离水蛭素,也会观察到爆发性的凝血酶生成。

相似文献

1
The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.重组水蛭素(CGP 39393)在血浆中的抗凝作用机制。
Thromb Haemost. 1990 Nov 30;64(3):464-8.
2
Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma.肝素和低分子量肝素可抑制凝血酶原酶的形成,但不抑制其在血浆中的活性。
Thromb Haemost. 1994 Dec;72(6):862-8.
3
HD1, a thrombin- and prothrombin-binding DNA aptamer, inhibits thrombin generation by attenuating prothrombin activation and thrombin feedback reactions.HD1 是一种凝血酶和凝血酶原结合的 DNA 适体,通过减弱凝血酶原激活和凝血酶反馈反应来抑制凝血酶生成。
Thromb Haemost. 2010 Jan;103(1):83-93. doi: 10.1160/TH09-04-0237. Epub 2009 Sep 15.
4
Experimental studies on a recombinant hirudin, CGP 39393.重组水蛭素CGP 39393的实验研究
Thromb Haemost. 1991 Apr 8;65(4):355-9.
5
The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.凝血酶激活途径在体外调节人血浆凝块的组装、结构和溶解。
Thromb Haemost. 1995 May;73(5):785-92.
6
Control mechanisms in thrombin generation.凝血酶生成中的控制机制。
Semin Thromb Hemost. 1996;22(4):303-8. doi: 10.1055/s-2007-999024.
7
Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.肝素和水蛭素对富血小板血浆内源性激活后凝血酶生成及血小板聚集的影响。
Thromb Haemost. 1995 Oct;74(4):1163-8.
8
Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.Bothrojaracin对凝血酶催化的因子V激活的抑制作用。
Thromb Haemost. 1998 Jun;79(6):1157-61.
9
Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.新型合成类肝素对大鼠体内外全血凝血酶生成的影响。
Thromb Haemost. 2002 Feb;87(2):238-44.
10
Inactivation of factor VIII by a mechanism independent of the generation of thrombin.通过一种独立于凝血酶生成的机制使凝血因子 VIII 失活。
Thromb Haemost. 1979 Oct 31;42(3):838-47.

引用本文的文献

1
Determinants of reduced antiplatelet effect of aspirin in patients with stable coronary artery disease.稳定型冠状动脉疾病患者阿司匹林抗血小板作用降低的决定因素。
PLoS One. 2015 May 18;10(5):e0126767. doi: 10.1371/journal.pone.0126767. eCollection 2015.
2
Effects of dabigatran in vitro on thrombin biomarkers by Calibrated Automated Thrombography in patients after ischemic stroke.达比加群对缺血性脑卒中患者经校准的自动化血栓弹力图检测的凝血酶生物标志物的体外影响。
J Thromb Thrombolysis. 2012 Jan;33(1):22-7. doi: 10.1007/s11239-011-0654-x.
3
Consistent pharmacokinetics of the oral direct thrombin inhibitor ximelagatran in patients with nonvalvular atrial fibrillation and in healthy subjects.
口服直接凝血酶抑制剂希美加群在非瓣膜性心房颤动患者和健康受试者中的药代动力学特征一致。
Eur J Clin Pharmacol. 2003 Oct;59(7):537-43. doi: 10.1007/s00228-003-0667-2. Epub 2003 Sep 4.
4
Thrombin: Structure, Biochemistry, Measurement, and Status in Clinical Medicine.凝血酶:结构、生物化学、检测及临床医学中的地位
J Thromb Thrombolysis. 1998 Jul;5(3):215-229. doi: 10.1023/A:1008843925851.
5
Hirudin, a new therapeutic tool?水蛭素,一种新的治疗工具?
Ann Hematol. 1991 Aug;63(2):67-76. doi: 10.1007/BF01707275.